Was built to EU-GMP standards, producing specialty drugs with some special dosage forms.
- The total invested capital was 470 billion VND.
- Scheduled to finish by the end of 2019, go into operation at the beginning of 2020, and reached EU-GMP standards in early 2022.
This is the factory with the highest scale of technology and investment fund of Imexpharm. IMP4 carries with it the most advanced technologies of the pharmaceutical industry in Vietnam such as the line of lyophilized powder for injection for both Steroid and Non-Steroid drug groups and the Blow Fill Seal (BFS) injection line. Average total capacity 23,940,000 units/year